|
|
Vaccine Detail
|
CTB-ESAT6-MPT64 |
| Vaccine Information |
- Vaccine Name: CTB-ESAT6-MPT64
- Target Pathogen: Mycobacterium tuberculosis
- Target Disease: Tuberculosis
- Type: Subunit vaccine
- Status: Research
- Host Species for Licensed Use: Rabbit
- Antigen: The antigen is composed of Mycobacterium tuberculosis antigens ESAT-6 and MPT-64 (Yadav et al., 2023).
- MPT64
gene engineering:
- Type: Fusion Protein
- Description: This is use in fusion protein preparation (Yadav et al., 2023).
- Detailed Gene Information: Click Here.
- EsxA (ESAT-6)
gene engineering:
- Type: Fusion Protein
- Description: It's use in prepare fusion protein (Yadav et al., 2023).
- Detailed Gene Information: Click Here.
- Adjuvant: CTB vaccine adjuvant
- Immunization Route: Mucosal (oral) immune route
|
| Host Response |
|
Rabbit Response
- Vaccination Protocol: Rabbits were orally immunized by feeding 3 g of transgenic cucumber fruit expressing the CTB-ESAT-6-MPT-64 fusion protein on days 0, 7, and 14, with serum collected on day 21 for immunological analysis (Yadav et al., 2023).
- Immune Response: Oral administration of transgenic cucumber expressing CTB-ESAT-6-MPT-64 induced a significant increase in antigen-specific serum IgG levels compared with rabbits fed non-transgenic cucumber, demonstrating effective immunogenicity of the fusion protein (Yadav et al., 2023).
|
| References |
Yadav et al., 2023: Yadav J, Phogat S, Chaudhary D, Jaiwal R, Jaiwal PK. Synthesis of plant-based, self-adjuvanted, dual antigen specific to Mycobacterium tuberculosis as a novel tuberculosis subunit vaccine that elicits immunogenicity in rabbit. Biotechnology letters. 2023; 45(5-6); 703-717. [PubMed: 37074553].
|
|